InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
15
T+90 hit rate
25%
T+90 mean return
-12.9%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Reynoso Jamie L., Chief Executive Officer of Medicare Advantage. Officer active across 1 company, notably Clover Health Investments, CORP. /de. Cumulatively, 69 disclosures have been published. Split: 0 buy · 15 sells. Total volume traded: €229k. History available since 16 July 2021. The latest transaction was filed on 15 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations69 total
2,360 sharesClass A Common StockSEC:0001839066-26-000024:0
6,350 sharesClass A Common StockSEC:0001839066-26-000022:0
7,289 sharesClass A Common StockSEC:0001839066-26-000017:0
●
12,712 shares@ US$2.040.0012% mcap1.6% of flowClass A Common StockSEC:0001839066-26-000015
●
12,712 shares@ US$2.040.0018% mcap1.6% of flowClass A Common StockSEC:0001839066-26-000015:0
●
6,197 shares@ US$1.720.0005% mcap0.4% of flowClass A Common StockSEC:0001839066-26-000014:0
●
14,732 shares@ US$2.812.6% of flowClass A Common StockSEC:0001801170-26-000024
●
14,732 shares@ US$2.810.0029% mcap2.6% of flowClass A Common StockSEC:0001801170-26-000024:0
2,102 shares@ US$2.530.3% of flowClass A Common StockSEC:0001839066-26-000004
2,102 shares@ US$2.530.0004% mcap0.3% of flowClass A Common StockSEC:0001839066-26-000004:0
●
8,109 shares@ US$2.411.2% of flowClass A Common StockSEC:0001839066-26-000002
●
8,109 shares@ US$2.410.0014% mcap1.2% of flowClass A Common StockSEC:0001839066-26-000002:0
▼
4,913 shares@ US$2.610.0009% mcap0.8% of flowClass A Common StockSEC:0001839066-25-000029:0
▼
4,913 shares@ US$2.610.8% of flowClass A Common StockSEC:0001839066-25-000029
▼
16,514 shares@ US$2.692.8% of flowClass A Common StockSEC:0001839066-25-000019
▼
16,514 shares@ US$2.690.0031% mcap2.8% of flowClass A Common StockSEC:0001839066-25-000019:0
●
71,432 shares@ US$2.800.014% mcap12.8% of flowClass A Common StockSEC:0001839066-25-000017:0
●
71,432 shares@ US$2.8012.8% of flowClass A Common StockSEC:0001839066-25-000017
●
8,706 shares@ US$2.591.4% of flowClass A Common StockSEC:0001801170-25-000240
●
8,706 shares@ US$2.590.0016% mcap1.4% of flowClass A Common StockSEC:0001801170-25-000240:0
2,012 shares@ US$2.650.2% of flowClass A Common StockSEC:0001801170-25-000240:1
▼
4,914 shares@ US$3.091.0% of flowClass A Common StockSEC:0001839066-25-000010
▼
4,914 shares@ US$3.090.0011% mcap1.0% of flowClass A Common StockSEC:0001839066-25-000010:0
●
85,596 shares@ US$2.7915.1% of flowClass A Common StockSEC:0001839066-25-000008
●
52,967 shares@ US$1.234.5% of flowClass A Common StockSEC:0001839066-25-000006
25 of 69 declarations
About Reynoso Jamie L.
Public sources show that Jamie L. Reynoso is the Chief Executive Officer of Medicare Advantage at Clover Health Investments, a role she has held since January 2023. Clover Health’s proxy statement says she previously served as the company’s Chief Operating Officer from July 2020 to January 2023, and before Clover Health she worked at Memorial Hermann Health Plan, Catholic Health Initiatives, and UnitedHealth Group. The same filing lists her as 55 years old and says she holds a B.B.A. from Texas A&M University-Kingsville. Sources: https://materials.proxyvote.com/Approved/18914F/20240415/NPS_574861.PDF
